Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES?

https://doi.org/10.20996/1819-6446-2009-5-1-33-36

Full Text:

Abstract

Aim. To find echocardiographic indicators of heart remodelling that improve estimation of heart failure (HF) severity. To evaluate sensitivity of laboratory markers of HF, brain (BNP) and atrial (ANP) natriuretic peptides, in patients with mitral heart diseases of rheumatic aetiology.

Material and methods. 100 patients with rheumatic mitral disease and chronic HF (CHF) of I-IV class (NYHA) were examined. Echocardiography was performed in all patients with evaluation of the standard indices to define disease severity. Indices of sphericity, myocardial stress of the left ventricle, etc were also evaluated. BNP and ANB levels were assessed by enzyme immunoassay method.

Results. CHF severity had the strongest correlations with atrial sizes, left atrial systolic function and level of pulmonary hypertension. Moderate increase of BNP level in severe CHF (III-IV class) and its rare increase in mild CHF (I-II class) were detected. Significant changes of ANP level were not found. Moderate correlation of BNP level with myocardium mass index, level of pulmonary hypertension and mitral regurgitation was detected.

Conclusion. Intensity of heart remodelling in rheumatic mitral diseases is mainly determined by the left atrial area, left atrial systolic function, mitral orifice size, levels of mitral regurgitation and pulmonary hypertension, size and ejection fraction of right ventricle. Normal BNP level does not confirm an absence of CHF or negative prognosis in patients with rheumatic heart disease.

About the Authors

T. A. Kazakovtseva
Russian State Medical University
Russian Federation

Nesterov Department of Faculty Therapy

Leninsky prosp. 8, korp. 10, Moscow, 117049 Russia



N. A. Shostak
Russian State Medical University
Russian Federation

Nesterov Department of Faculty Therapy

Leninsky prosp. 8, korp. 10, Moscow, 117049 Russia



References

1. Либов И.А., Немировская А.И.. Бета-блокаторы при ХСН. Показания и противопоказания. Как найти равновесие? РМЖ 2004; 12(15):932-5.

2. Мареев В.Ю., Даниелян М.О., Беленков Ю.Н. Сравнительная характеристика больных с ХСН в зависимости от величины фракции выброса по результатам российского многоцентрового исследования ЭПОХА–О–ХСН: снова о проблеме ХСН с сохранной систолической функцией левого желудочка. Журнал Сердечная недостаточность 2006;7(4):164-71.

3. WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. Geneva: WHO; 2004.

4. Белов В.В., Ильичёва О.Е. Использование мозгового натрийуретического пептида в диагностике сердечной недостаточности у больных, находящихся на лечении хроническим гемодиализом. Журнал Сердечная недостаточность 2007;8(5):184-6.

5. Kazanegra R., Cheng V., Garcia A. et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001;7(1):21-9.

6. Maeda K., Tsutamoto T., Wada A. et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135(5 Pt 1):825-32.

7. Шиллер Н., Осипов М.А. Клиническая эхокардиография. М.: Мир; 1993.

8. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета программ Statistica. М.: МедиаСфера; 2006.

9. Фейгенбаум Х. Эхокардиграфия. М.: Видар; 1999.

10. Калюжин В.В., Калюжин О.В., Тепляков А.Т., Караулов А.В. Хроническая сердечная недостаточность. М.: МИА; 2006.

11. Weber M., Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006;92(6):843-9.


For citation:


Kazakovtseva T.A., Shostak N.A. ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? Rational Pharmacotherapy in Cardiology. 2009;5(1):33-36. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-1-33-36

Views: 300


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)